253 related articles for article (PubMed ID: 22112992)
61. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
Maksten EF; Vase MØ; Kampmann J; d'Amore F; Møller MB; Strandhave C; Bendix K; Bistrup C; Thiesson HC; Søndergaard E; Hamilton-Dutoit S; Jespersen B
Transpl Int; 2016 Apr; 29(4):483-93. PubMed ID: 26749337
[TBL] [Abstract][Full Text] [Related]
62. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients.
Lim GY; Newman B; Kurland G; Webber SA
Radiology; 2002 Mar; 222(3):699-708. PubMed ID: 11867788
[TBL] [Abstract][Full Text] [Related]
63. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience.
Jain A; Nalesnik M; Reyes J; Pokharna R; Mazariegos G; Green M; Eghtesad B; Marsh W; Cacciarelli T; Fontes P; Abu-Elmagd K; Sindhi R; Demetris J; Fung J
Ann Surg; 2002 Oct; 236(4):429-36; discussion 436-7. PubMed ID: 12368671
[TBL] [Abstract][Full Text] [Related]
64. High incidence of posttransplant lymphoproliferative disease in pediatric patients with cystic fibrosis.
Cohen AH; Sweet SC; Mendeloff E; Mallory GB; Huddleston CB; Kraus M; Kelly M; Hayashi R; DeBaun MR
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1252-5. PubMed ID: 10764320
[TBL] [Abstract][Full Text] [Related]
65. Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases.
Paranjothi S; Yusen RD; Kraus MD; Lynch JP; Patterson GA; Trulock EP
J Heart Lung Transplant; 2001 Oct; 20(10):1054-63. PubMed ID: 11595560
[TBL] [Abstract][Full Text] [Related]
66. Post-transplant lymphoproliferative disorder after pancreas transplantation: a United Network for Organ Sharing database analysis.
Jackson K; Ruppert K; Shapiro R
Clin Transplant; 2013; 27(6):888-94. PubMed ID: 24118329
[TBL] [Abstract][Full Text] [Related]
67. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.
Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T
Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553
[TBL] [Abstract][Full Text] [Related]
68. Impact of the posttransplant lymphoproliferative disorder subtype on survival.
Koff JL; Li JX; Zhang X; Switchenko JM; Flowers CR; Waller EK
Cancer; 2018 Jun; 124(11):2327-2336. PubMed ID: 29579330
[TBL] [Abstract][Full Text] [Related]
69. Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.
Yoon JH; Lee S; Kim HJ; Lee JW; Min WS; Chung BH; Yang CW; Kim YS; Kim JI; Moon IS; Oh EJ; Park GS; Cho SG
Transpl Int; 2014 Jul; 27(7):721-32. PubMed ID: 24684689
[TBL] [Abstract][Full Text] [Related]
70. Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival.
Serre JE; Michonneau D; Bachy E; Noël LH; Dubois V; Suberbielle C; Kreis H; Legendre C; Mamzer-Bruneel MF; Morelon E; Thaunat O
Kidney Int; 2014 Jan; 85(1):182-90. PubMed ID: 23802193
[TBL] [Abstract][Full Text] [Related]
71. Pediatric Gastrointestinal Posttransplant Lymphoproliferative Disorder: Incidence, Clinical Characteristics, and Impact of Major Surgical Interventions Upon Overall Survival.
Dziegielewski C; Contreras R; Weitzman S; Gerstle JT
J Pediatr Hematol Oncol; 2018 Aug; 40(6):438-444. PubMed ID: 29794643
[TBL] [Abstract][Full Text] [Related]
72. Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation.
Wigle DA; Chaparro C; Humar A; Hutcheon MA; Chan CK; Keshavjee S
Transplantation; 2001 Dec; 72(11):1783-6. PubMed ID: 11740388
[TBL] [Abstract][Full Text] [Related]
73. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
Izadi M; Fazel M; Saadat SH; Taheri S
J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
[TBL] [Abstract][Full Text] [Related]
74. Allograft involvement by lymphoproliferative disorders after lung transplantation: report from the PTLD. Int survey.
Izadi M; Taheri S
Prog Transplant; 2011 Dec; 21(4):353-9. PubMed ID: 22549000
[TBL] [Abstract][Full Text] [Related]
75. Clinical characteristics and outcomes of PTLD following intestinal transplantation.
Wozniak LJ; Mauer TL; Venick RS; Said JW; Kao RL; Kempert P; Marcus EA; Hwang V; Cheng EY; Busuttil RW; McDiarmid SV; Farmer DG
Clin Transplant; 2018 Aug; 32(8):e13313. PubMed ID: 29888807
[TBL] [Abstract][Full Text] [Related]
76. [Lymphoproliferative disorders in kidney transplant recipients: incidence, clinical characteristics and outcome].
Abderrahim E; Harzallah A; Barbouch S; Turki S; Helal I; Ben Abdallah T; Hedri H; Ben Moussa F; Bardi R; Ayed K; Ben Maïz H; Kheder A
Rev Med Interne; 2008 Jul; 29(7):535-40. PubMed ID: 18262684
[TBL] [Abstract][Full Text] [Related]
77. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619
[TBL] [Abstract][Full Text] [Related]
78. Post-transplant Lymphoproliferative Disorder: A Single-Center Experience.
Ferreira H; Bustorff M; Santos J; Ferreira I; Sampaio S; Salomé I; Bastos J; Bergantim R; Príncipe F; Pestana M
Transplant Proc; 2015 May; 47(4):981-4. PubMed ID: 26036499
[TBL] [Abstract][Full Text] [Related]
79. Early versus late outset of lymphoproliferative disorders post-heart and lung transplantation: the PTLD.Int Survey.
Khedmat H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(1):10-6. PubMed ID: 21460602
[TBL] [Abstract][Full Text] [Related]
80. Post-transplant lymphoproliferative disease in liver transplant recipients.
Rubio-Manzanares Dorado M; Álamo Martínez JM; Bernal Bellido C; Marín Gómez LM; Suárez Artacho G; Cepeda Franco C; Wang J; Gómez Bravo MÁ; Padillo FJ
Rev Esp Enferm Dig; 2017 Jun; 109(6):406-413. PubMed ID: 28508661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
